Jacob Gerstenberg, Hartwig Klinker, Michael Baier, Amrei von Braun, Ulrich Seybold, Carlotta Helbig, Martin Däumer, Klaus Korn, Christoph Stephan, Benjamin T Schleenvoigt
{"title":"用于治疗 HIV-1 感染的长效利匹韦林和卡博替拉韦的治疗药物监测 - 五名患者在出现两类抗药性后出现一次病毒学失败的病例系列研究","authors":"Jacob Gerstenberg, Hartwig Klinker, Michael Baier, Amrei von Braun, Ulrich Seybold, Carlotta Helbig, Martin Däumer, Klaus Korn, Christoph Stephan, Benjamin T Schleenvoigt","doi":"10.1093/ofid/ofae480","DOIUrl":null,"url":null,"abstract":"Virologic failure of long-acting rilpivirine/cabotegravir is rare but may result in severely limited treatment options. Known risk factors cannot predict all cases. Therapeutic drug monitoring (TDM) may help identify patients-at-risk, but reliable thresholds are missing. We report retrospective TDM in a cohort of five patients, including one virological failure.","PeriodicalId":19517,"journal":{"name":"Open Forum Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Therapeutic Drug Monitoring of Long Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection – A Case Series of Five Patients with One Virologic Failure after Development of Two-Class Resistance\",\"authors\":\"Jacob Gerstenberg, Hartwig Klinker, Michael Baier, Amrei von Braun, Ulrich Seybold, Carlotta Helbig, Martin Däumer, Klaus Korn, Christoph Stephan, Benjamin T Schleenvoigt\",\"doi\":\"10.1093/ofid/ofae480\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Virologic failure of long-acting rilpivirine/cabotegravir is rare but may result in severely limited treatment options. Known risk factors cannot predict all cases. Therapeutic drug monitoring (TDM) may help identify patients-at-risk, but reliable thresholds are missing. We report retrospective TDM in a cohort of five patients, including one virological failure.\",\"PeriodicalId\":19517,\"journal\":{\"name\":\"Open Forum Infectious Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2024-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Forum Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ofid/ofae480\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Forum Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ofid/ofae480","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Therapeutic Drug Monitoring of Long Acting Rilpivirine and Cabotegravir for Treatment of HIV-1 Infection – A Case Series of Five Patients with One Virologic Failure after Development of Two-Class Resistance
Virologic failure of long-acting rilpivirine/cabotegravir is rare but may result in severely limited treatment options. Known risk factors cannot predict all cases. Therapeutic drug monitoring (TDM) may help identify patients-at-risk, but reliable thresholds are missing. We report retrospective TDM in a cohort of five patients, including one virological failure.
期刊介绍:
Open Forum Infectious Diseases provides a global forum for the publication of clinical, translational, and basic research findings in a fully open access, online journal environment. The journal reflects the broad diversity of the field of infectious diseases, and focuses on the intersection of biomedical science and clinical practice, with a particular emphasis on knowledge that holds the potential to improve patient care in populations around the world. Fully peer-reviewed, OFID supports the international community of infectious diseases experts by providing a venue for articles that further the understanding of all aspects of infectious diseases.